Login / Signup
Emerging safety issues in alemtuzumab-treated MS patients.
Joep Killestein
Bob van Oosten
Published in:
Multiple sclerosis (Houndmills, Basingstoke, England) (2020)
Keyphrases
</>
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
multiple sclerosis
mass spectrometry
peritoneal dialysis
ms ms
patient reported outcomes
patient reported